Showing 15 posts of 467 posts found.


Long COVID: 15 studies launched with £19.6 million government funding

July 19, 2021
Sales and Marketing NHS, UK, long covid

The UK government has announced the launch of 15 new extensive studies, backed by £19.6 million in funding, to investigate …

Drugmakers fined a record £260 million after 10,000% drug price increase

July 16, 2021
Medical Communications UK

The UK’s competition authority has issued its largest ever fine of more than £260 million ($360 million) to several pharma …


New targeted lung cancer treatment coming to UK under MHRA scheme

July 15, 2021
MHRA, NSCLC, UK, brexit

The MHRA has issued an Early Access to Medicines Scheme (EAMS) positive scientific opinion for tepotinib, for the treatment of …

Summer COVID cases set to reach 2 million with 10 million isolating

July 7, 2021
Research and Development COVID-19, Lockdown, UK, Vaccine, government

Analysis from the Guardian has found that over two million people could contract COVID-19 this summer, which could therefore lead …


Over 600,000 positive COVID tests genomically sequenced in UK

July 5, 2021
Sales and Marketing COVID-19, Delta variant, UK, government, variant

The UK has genomically sequenced more than 600,000 positive COVID-19 test, it was announced on Friday. Genomic sequencing plays a …

Survey reveals over 2 million people impacted by long COVID in UK

June 24, 2021
COVID-19, UK, government, long covid, study

A recent survey from Imperial College London has revealed that over 2 million people in the UK may have suffered …

UK COVID vaccine update

June 16, 2021
Research and Development COVID-19, UK, care homes, children, government, vaccines

Care home staff vaccinations to be compulsory COVID-19 vaccinations among care home staff are to become mandatory, the Guardian has …

Ground-breaking COVID antibody treatment proven to save lives

June 16, 2021
Research and Development COVID-19, UK, antibodies, trial

Results from Regeneron’s Recovery trial, investigating a potent monoclonal antibody combination treatment in hospitalised patients with severe COVID-19, have shown …

G7: UK to donate 100 million surplus vaccine doses

June 11, 2021
Medical Communications Boris Johnson, COVID-19, G7, Joe Biden, UK, US, Vaccine

Boris Johnson has announced at the G7 meeting in Cornwall that the UK will donate over 100 million surplus doses …

NICE recommends Janssen’s active psoriatic arthritis drug

May 28, 2021
Medical Communications Janssen, NICE, UK, arthritis

NICE have released a Final Appraisal Document (FAD) recommending Janssen’s tremfya (guselkumab) as a new option for treating active psoriatic …


GSK to support manufacture of 60m Novavax COVID-19 vaccines

March 30, 2021
Manufacturing and Production COVID-19, GSK, UK, Vaccine

GSK has reached an agreement with Novavax and the UK Government Vaccines Taskforce to support the production of up to …


Camallergy awarded £1.1m government funding for peanut allergy immunotherapy

March 9, 2021
Manufacturing and Production Camallergy, UK, allergy

Camallergy, a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for life-threatening food allergies, today announced it has been awarded …


Seven mass vaccination sites open in England

January 11, 2021
Sales and Marketing COVID-19, UK, Vaccine

Seven mass vaccination centres have opened in England today as the government works to vaccinate as many people as possible …


New coronavirus strain identified in the UK

December 15, 2020
Manufacturing and Production, Research and Development COVID-19, UK, coronavirus, vaccines

A new variant of coronavirus has been identified in the UK, and is growing faster in some parts of England, …


MHRA warns patients with history of significant allergic reactions not to receive Pfizer/BioNTech COVID-19 vaccine

December 9, 2020
Research and Development COVID-19, MHRA, UK, Vaccine

While the rolling out of Pfizer and BioNTech’s COVID-19 in the UK this week marked a historic moment in a …

Latest content